Increased cerebrospinal fluid tau protein in multiple sclerosis

European Neurology

Volumn 43, Issue 4, 2000, Pages 228-232

  Kapaki, Elisabeth ^a   Paraskevas, George P ^a   Michalopoulou, Maria ^a   Kilidireas, Konstantinos ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Amyotrophic lateral sclerosis; Cerebrospinal fluid; Multiple sclerosis; Tau protein

Indexed keywords

TAU PROTEIN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NERVE FIBER; NERVE INJURY; PRIORITY JOURNAL;

EID: 0034118306     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000008181     Document Type: Article

References (14)

1. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L: Axon transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-285.
2. Ferguson B, Matyszak MK, Esiri MM, Perry VH: Axonal damage in acute multiple sclerosis lesions. Brain 1997;120:393-399.
3. Scolding N, Franklin R: Axon loss in multiple sclerosis. Lancet 1998;352:340-341.
4. Kosik KS, Greenberg SM: Tau protein and Alzheimer's disease; in Terry RD, Katzman R, Bick KL (eds): Alzheimer's Disease. New York, Raven Press, 1994, pp 335-344.
5. Vandermeeren M, Mercken M, Vanmechelen E, Six J, Van de Voorde A, Martin J-J, Cras P: Detection of τ proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunoabsorbent assay. J Neurochem 1993;61:1828-1834.
6. Trojanowski JQ, Clark CM, Arai H, et al: Elevated levels of tau in cerebrospinal fluid: Implications for the antemortem diagnosis in Alzheimer's disease. Alzheimer Dis Rev 1996;1: 77-83.
7. Feany MB, Dickson DW: Neurodegenerative disorders with extensive Tau pathology: A comparative study and review. Ann Neurol 1996;40:139-148.
8. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW: New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983;13:227-231.
9. Francis GS, Duquette P, Antel JP: Inflammatory demyelinating diseases of the central nervous system; in Bradley WG, Daroff RB, Fenichel GM, Marsden CD (eds): Neurology in Clinical Practice. Boston, Butterworth-Heinemann, 1996, vol II, pp 1307-1343.
10. Brooks BR: El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial 'Clinical limits of amyotrophic lateral sclerosis' workshop contributors. J Neurol Sci 1994;124(suppl):96-107.
11. Mori H, Hosoda K, Matsubara E, Nakamoto T, Furiya Y, Endoh R, Usami M, Shoji M, Maruyama S, Hirai S: Tau in cerebrospinal fluids: Establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau. Neurosci Lett 1995;186:181-183.
12. Johnson GVW, Seubert P, Cox TM, Motter R, Brown JP, Galasko D: The τ protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments. J Neurochem 1997;68:430-433.
13. Adams JH, Graham DI, Gennarelli TA, Maxwell WL: Diffuse axonal injury in nonmissile head injury. J Neurol Neurosurg Psychiatry 1991;54:481-483.
14. Trapp BD, Ransohoff R, Rudick R: Axonal pathology in multiple sclerosis: Relationship to neurologic disability. Curr Opin Neurol 1999; 12:295-302.